Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

SELL
$113.38 - $135.49 $3,514 - $4,200
-31 Reduced 79.49%
8 $1.01 Million
Q1 2025

Apr 29, 2025

BUY
$133.43 - $153.27 $2,535 - $2,912
19 Added 95.0%
39 $5.34 Million
Q4 2024

Jan 30, 2025

BUY
$146.47 - $191.55 $2,929 - $3,831
20 New
20 $3.06 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $24.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sierra Ocean, LLC Portfolio

Follow Sierra Ocean, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Ocean, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Ocean, LLC with notifications on news.